| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.34B | +40.2% |
| Gross Profit | $4.67B | +45.3% |
| R&D Expense | $2.15B | +9.9% |
| SG&A Expense | $2.08B | +13.7% |
| Operating Income | $447.1M | +178.7% |
| Interest Expense | $50.0M | +6.5% |
| Pre-tax Income | $416.9M | +178.2% |
| Income Tax | $129.9M | +16.2% |
| Net Income | $286.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.55B | +73.1% |
| Accounts Receivable | $865.1M | +27.9% |
| Inventory | $608.2M | +22.9% |
| Current Assets | $6.23B | +56.2% |
| Total Assets | $8.19B | +38.3% |
| Current Liabilities | $1.83B | -17.4% |
| Long-term Debt | $836.4M | +402.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.13B | +901.8% |
| Capital Expenditures | $185.8M | -62.3% |
| Investing Cash Flow | -$276.2M | +49.6% |
| Financing Cash Flow | $1.06B | +447.7% |
| Free Cash Flow | $941.7M | +248.7% |
| +144.5% |
| EPS (Basic) | $0.20 | +142.6% |
| EPS (Diluted) | $0.19 | +140.4% |
| Total Liabilities |
| $3.83B |
| +47.9% |
| Stockholders' Equity | $4.36B | +30.9% |